• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人隐匿性自身免疫性糖尿病与 2 型糖尿病的临床特征与慢性并发症之间的关系。

Associations between clinical characteristics and chronic complications in latent autoimmune diabetes in adults and type 2 diabetes.

机构信息

Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Diabetes Institute, Shanghai Clinical Center for Diabetes, Shanghai, China.

出版信息

Diabetes Metab Res Rev. 2015 May;31(4):411-20. doi: 10.1002/dmrr.2626. Epub 2015 Jan 23.

DOI:10.1002/dmrr.2626
PMID:25448723
Abstract

BACKGROUND

This study aimed to assess the associations between clinical characteristics and chronic complications in latent autoimmune diabetes in adults (LADA) and type 2 diabetes.

METHODS

This is a retrospective study. Our diabetes registry included 6975 patients aged 30-75 years old with phenotypic type 2 diabetes who underwent islet autoantibody screening between 2003 and 2012; 384 patients were identified to have LADA. Rates of chronic complications for LADA and type 2 diabetes were compared using a 1 : 2 matched design. Logistic models were fitted to identify the presence of chronic diabetic complications using clinical characteristics including gender, age, duration of diabetes, glycemic control and metabolic syndrome.

RESULTS

When duration of diabetes is <5 years, the prevalence of diabetic nephropathy (nephropathy; 12.2% versus 21.8%, p = 0.018) and diabetic retinopathy (retinopathy; 8.1% versus 15.9%, p = 0.011) were significantly lower in patients with LADA than in patients with type 2 diabetes; the prevalence of nephropathy and retinopathy were comparable between both groups when duration is ≥5 years. There was no significant difference in the prevalence of macrovascular complications between groups. The areas under the receiver operating characteristic curves based on the nephropathy and retinopathy models were larger for LADA than for type 2 diabetes (0.72 versus 0.61, p = 0.013; 0.76 versus 0.68, p = 0.056).

CONCLUSIONS

Patients with LADA had a lower prevalence of microvascular complications than patients with type 2 diabetes when the duration of diabetes was <5 years. Regression equation fitted by clinical characteristics can better predict the risk of microvascular complications in LADA than in type 2 diabetes.

摘要

背景

本研究旨在评估成人隐匿性自身免疫性糖尿病(LADA)和 2 型糖尿病患者的临床特征与慢性并发症之间的关联。

方法

这是一项回顾性研究。我们的糖尿病登记处包括 6975 名年龄在 30-75 岁之间的表型 2 型糖尿病患者,他们在 2003 年至 2012 年间接受了胰岛自身抗体筛查;其中 384 名患者被诊断为 LADA。使用 1:2 匹配设计比较 LADA 和 2 型糖尿病的慢性并发症发生率。使用包括性别、年龄、糖尿病病程、血糖控制和代谢综合征在内的临床特征,通过逻辑模型来确定慢性糖尿病并发症的存在。

结果

当糖尿病病程<5 年时,LADA 患者的糖尿病肾病(肾病;12.2%比 21.8%,p=0.018)和糖尿病视网膜病变(视网膜病变;8.1%比 15.9%,p=0.011)的患病率明显低于 2 型糖尿病患者;当病程≥5 年时,两组患者的肾病和视网膜病变患病率相当。两组之间大血管并发症的患病率没有显著差异。基于肾病和视网膜病变模型的受试者工作特征曲线下面积(AUC),LADA 大于 2 型糖尿病(0.72 比 0.61,p=0.013;0.76 比 0.68,p=0.056)。

结论

当糖尿病病程<5 年时,LADA 患者的微血管并发症患病率低于 2 型糖尿病患者。由临床特征拟合的回归方程能更好地预测 LADA 患者微血管并发症的风险,优于 2 型糖尿病患者。

相似文献

1
Associations between clinical characteristics and chronic complications in latent autoimmune diabetes in adults and type 2 diabetes.成人隐匿性自身免疫性糖尿病与 2 型糖尿病的临床特征与慢性并发症之间的关系。
Diabetes Metab Res Rev. 2015 May;31(4):411-20. doi: 10.1002/dmrr.2626. Epub 2015 Jan 23.
2
Evaluating peripheral nerve function in asymptomatic patients with type 2 diabetes or latent autoimmune diabetes of adults (LADA): results from nerve conduction studies.评估2型糖尿病或成人隐匿性自身免疫性糖尿病(LADA)无症状患者的周围神经功能:神经传导研究结果
J Diabetes Complications. 2015 Mar;29(2):265-9. doi: 10.1016/j.jdiacomp.2014.11.001. Epub 2014 Nov 13.
3
The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus.成年潜伏性自身免疫性糖尿病的临床特征及其与代谢控制不佳的土耳其2型糖尿病患者慢性并发症的关系。
J Diabetes Complications. 2005 Sep-Oct;19(5):254-8. doi: 10.1016/j.jdiacomp.2005.02.004.
4
Orthostatic hypotension in diabetic patients-10-year follow-up study.糖尿病患者的直立性低血压——10年随访研究
J Diabetes Complications. 2016 Jan-Feb;30(1):67-71. doi: 10.1016/j.jdiacomp.2015.08.020. Epub 2015 Sep 2.
5
Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA).
Diabetes Care. 1999 Aug;22(8):1347-53. doi: 10.2337/diacare.22.8.1347.
6
[Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].[成人隐匿性自身免疫性糖尿病(LADA):自身免疫性起源的1型糖尿病临床谱的一部分]
Orv Hetil. 2001 Nov 18;142(46):2571-8.
7
Zinc transporter 8 autoantibody (ZnT8A) could help differentiate latent autoimmune diabetes in adults (LADA) from phenotypic type 2 diabetes mellitus.锌转运体 8 自身抗体(ZnT8A)有助于区分成人隐匿性自身免疫性糖尿病(LADA)与表型 2 型糖尿病。
Diabetes Metab Res Rev. 2013 Jul;29(5):363-8. doi: 10.1002/dmrr.2396.
8
Diabetic neuropathy in patients with "latent autoimmune diabetes of the adults" (LADA) compared with patients with type 1 and type 2 diabetes.“成人隐匿性自身免疫性糖尿病”(LADA)患者的糖尿病神经病变与1型和2型糖尿病患者的比较。
J Neurol. 2003 Jun;250(6):682-7. doi: 10.1007/s00415-003-1055-7.
9
Increased serum concentrations of adhesion molecules but not of chemokines in patients with Type 2 diabetes compared with patients with Type 1 diabetes and latent autoimmune diabetes in adult age: action LADA 5.与 1 型糖尿病和成人隐匿性自身免疫性糖尿病患者相比,2 型糖尿病患者血清黏附分子浓度升高,但趋化因子浓度没有升高:LADA5 研究。
Diabet Med. 2012 Apr;29(4):470-8. doi: 10.1111/j.1464-5491.2011.03546.x.
10
[A nationwide retrospective analysis on chronic diabetic complications and related macrovascular diseases of in-patients with diabetes during 1991-2000].[1991 - 2000年糖尿病住院患者慢性糖尿病并发症及相关大血管疾病的全国性回顾性分析]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2002 Oct;24(5):447-51.

引用本文的文献

1
Prognosis and outcome of latent autoimmune diabetes in adults: T1DM or T2DM?成人隐匿性自身免疫性糖尿病的预后与转归:1型糖尿病还是2型糖尿病?
Diabetol Metab Syndr. 2024 Oct 7;16(1):242. doi: 10.1186/s13098-024-01479-6.
2
Latent autoimmune diabetes in adults in China.中国成年人隐匿性自身免疫糖尿病。
Front Immunol. 2022 Aug 25;13:977413. doi: 10.3389/fimmu.2022.977413. eCollection 2022.
3
Latent Autoimmune Diabetes in Adults (LADA) and its Metabolic Characteristics among Yemeni Type 2 Diabetes Mellitus Patients.也门2型糖尿病患者中的成人隐匿性自身免疫性糖尿病(LADA)及其代谢特征
Diabetes Metab Syndr Obes. 2021 Oct 13;14:4223-4232. doi: 10.2147/DMSO.S332416. eCollection 2021.
4
Is diabetic retinopathy affected by diabetes type? A retrospective study using electronic medical record data from patients with latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes.糖尿病视网膜病变是否受糖尿病类型影响?一项使用成人隐匿性自身免疫性糖尿病、1 型糖尿病和 2 型糖尿病患者电子病历数据的回顾性研究。
Acta Diabetol. 2021 Nov;58(11):1503-1511. doi: 10.1007/s00592-021-01748-0. Epub 2021 Jun 13.
5
Relationships between Islet-Specific Autoantibody Titers and the Clinical Characteristics of Patients with Diabetes Mellitus.胰岛自身抗体滴度与糖尿病患者临床特征的关系。
Diabetes Metab J. 2021 May;45(3):404-416. doi: 10.4093/dmj.2019.0239. Epub 2020 Jul 21.
6
Daily Branched-Chain Amino Acid Intake and Risks of Obesity and Insulin Resistance in Children: A Cross-Sectional Study.每日支链氨基酸摄入量与儿童肥胖和胰岛素抵抗风险的横断面研究。
Obesity (Silver Spring). 2020 Jul;28(7):1310-1316. doi: 10.1002/oby.22834. Epub 2020 Jun 8.
7
Glucose metabolism among obese and non-obese children of mothers with gestational diabetes.母亲患有妊娠糖尿病的肥胖和非肥胖儿童的葡萄糖代谢。
BMJ Open Diabetes Res Care. 2020 Mar;8(1). doi: 10.1136/bmjdrc-2019-000822.
8
Joint Associations of Maternal Gestational Diabetes and Hypertensive Disorders of Pregnancy With Overweight in Offspring.母亲妊娠期糖尿病和妊娠高血压疾病与子代超重的联合关联
Front Endocrinol (Lausanne). 2019 Sep 20;10:645. doi: 10.3389/fendo.2019.00645. eCollection 2019.
9
Type 2 Diabetes: How Much of an Autoimmune Disease?2型糖尿病:在多大程度上属于自身免疫性疾病?
Front Endocrinol (Lausanne). 2019 Jul 4;10:451. doi: 10.3389/fendo.2019.00451. eCollection 2019.
10
Latent Autoimmune Diabetes in Adults: Current Status and New Horizons.成人隐匿性自身免疫性糖尿病:现状与新进展
Endocrinol Metab (Seoul). 2018 Jun;33(2):147-159. doi: 10.3803/EnM.2018.33.2.147.